As COVID-19 adversely affects patients with cancer, prophylactic strategies are critically
needed. Using a validated antibody assay against SARS-CoV-2 spike protein, we determined a …

The addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP)
chemotherapy results in significant improvement in clinical outcome for individuals with …

Background Prior studies with the use of a prospective–retrospective design including
archival tumor samples have shown that gene-expression assays provide clinically useful …

Background We compared the efficacy of two different taxanes, docetaxel and paclitaxel,
given either weekly or every 3 weeks, in the adjuvant treatment of breast cancer. Methods We …

Background The recurrence score based on the 21-gene breast cancer assay predicts
chemotherapy benefit if it is high and a low risk of recurrence in the absence of chemotherapy if it …

COVID-19 in patients with cancer is associated with a significantly increased risk of case
fatality, suggesting the need for proactive strategies to reduce likelihood of infection and …

Purpose Recent studies suggest that tumor-infiltrating lymphocytes (TILs) are associated
with disease-free (DFS) and overall survival (OS) in operable triple-negative breast cancer (…

Background Neoadjuvant chemotherapy (NACT) for early breast cancer can make breast-conserving
surgery more feasible and might be more likely to eradicate micrometastatic …

Purpose Standardized definitions of breast cancer clinical trial end points must be adopted
to permit the consistent interpretation and analysis of breast cancer clinical trials and to …

Background The incidence of anal cancer is substantially higher among persons living with
the human immunodeficiency virus (HIV) than in the general population. Similar to cervical …